Variant report
Variant | nsv520999 |
---|---|
Chromosome Location | chr16:76271568-76277895 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:20)
- CpG islands (count:61)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:20 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr16:76276619-76276914 | HepG2 | liver: | n/a | chr16:76276751-76276762 |
2 | E2F4 | chr16:76276713-76276959 | MCF10A-Er-Src | breast: | n/a | n/a |
3 | MAFF | chr16:76277560-76277872 | K562 | blood: | n/a | chr16:76277705-76277723 chr16:76277711-76277725 |
4 | MAFF | chr16:76277534-76277901 | HepG2 | liver: | n/a | chr16:76277705-76277723 chr16:76277711-76277725 |
5 | MAFK | chr16:76277558-76277873 | Hela-S3 | cervix: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
6 | MAFK | chr16:76277532-76277897 | IMR90 | lung: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
7 | MAFK | chr16:76277532-76277889 | HepG2 | liver: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
8 | MAFK | chr16:76277548-76277862 | K562 | blood: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
9 | MAFK | chr16:76277549-76278089 | H1-hESC | embryonic stem cell: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
10 | MAFK | chr16:76277530-76277901 | HepG2 | liver: | n/a | chr16:76277708-76277728 chr16:76277710-76277726 chr16:76277711-76277725 chr16:76277707-76277722 |
11 | MYC | chr16:76271594-76271642 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr16:76272068-76272152 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr16:76276569-76276620 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | RAD21 | chr16:76275846-76276034 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | RAD21 | chr16:76275754-76276105 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | RAD21 | chr16:76275824-76276073 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | RFX5 | chr16:76273685-76273721 | GM12878 | blood: | n/a | n/a |
18 | RXRA | chr16:76274785-76274969 | HepG2 | liver: | n/a | n/a |
19 | YY1 | chr16:76271462-76271669 | GM12878 | blood: | n/a | chr16:76271564-76271586 chr16:76271574-76271586 |
20 | YY1 | chr16:76271429-76271728 | H1-hESC | embryonic stem cell: | n/a | chr16:76271564-76271586 chr16:76271574-76271586 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:76272351-76272401 | K562 | blood: | n/a |
2 | chr16:76272351-76272401 | U87 | brain: | n/a |
3 | chr16:76272351-76272401 | T-47D | breast: | n/a |
4 | chr16:76272351-76272401 | AG09319 | gingival: | n/a |
5 | chr16:76272351-76272401 | GM19239 | blood: | n/a |
6 | chr16:76272351-76272401 | Hela-S3 | cervix: | n/a |
7 | chr16:76272351-76272401 | AG04450 | lung: | fetal |
8 | chr16:76272351-76272401 | GM12878 | blood: | n/a |
9 | chr16:76272351-76272401 | GM12892 | blood: | n/a |
10 | chr16:76272351-76272401 | HCM | heart: | n/a |
11 | chr16:76272351-76272401 | HMEC | breast: | n/a |
12 | chr16:76272351-76272401 | HCPEpiC | choroid plexus: | n/a |
13 | chr16:76272351-76272401 | MCF-7 | breast: | n/a |
14 | chr16:76272351-76272401 | LNCaP | prostate: | n/a |
15 | chr16:76272351-76272401 | IMR90 | lung: | fetal |
16 | chr16:76272351-76272401 | HCT-116 | colon: | n/a |
17 | chr16:76272351-76272401 | AG04449 | skin: | fetal |
18 | chr16:76272351-76272401 | Caco-2 | colon: | n/a |
19 | chr16:76272351-76272401 | HCF | heart: | n/a |
20 | chr16:76272351-76272401 | CMK | blood: | n/a |
21 | chr16:76272351-76272401 | HRPEpiC | eye: | n/a |
22 | chr16:76272351-76272401 | GM12891 | blood: | n/a |
23 | chr16:76272351-76272401 | SK-N-SH_RA | brain: | n/a |
24 | chr16:76272351-76272401 | RPTEC | kidney: | n/a |
25 | chr16:76272351-76272401 | Hepatocyte | liver: | n/a |
26 | chr16:76272351-76272401 | NB4 | blood: | n/a |
27 | chr16:76272351-76272401 | HEK293 | kidney: | embryo |
28 | chr16:76272351-76272401 | HL-60 | blood: | n/a |
29 | chr16:76272351-76272401 | MCF10A-Er-Src | breast: | n/a |
30 | chr16:76272351-76272401 | HEEpiC | esophagus: | n/a |
31 | chr16:76272351-76272401 | SK-N-SH | brain: | n/a |
32 | chr16:76272351-76272401 | PrEC | prostate: | n/a |
33 | chr16:76272351-76272401 | SAEC | small airway: | n/a |
34 | chr16:76272351-76272401 | AoSMC | blood vessel: | n/a |
35 | chr16:76272351-76272401 | NH-A | brain: | n/a |
36 | chr16:76272351-76272401 | HIPEpiC | eye: | n/a |
37 | chr16:76272351-76272401 | NT2-D1 | testis: | n/a |
38 | chr16:76272351-76272401 | HRCEpiC | kidney: | n/a |
39 | chr16:76272351-76272401 | PFSK-1 | brain: | n/a |
40 | chr16:76272351-76272401 | H1-hESC | embryonic stem cell: | embryo |
41 | chr16:76272351-76272401 | SKMC | muscle: | n/a |
42 | chr16:76272351-76272401 | AG10803 | skin: | n/a |
43 | chr16:76272351-76272401 | PANC-1 | pancreas: | n/a |
44 | chr16:76272351-76272401 | HAEpiC | amniotic membrane: | n/a |
45 | chr16:76272351-76272401 | NHBE | bronchial: | n/a |
46 | chr16:76272351-76272401 | HUVEC | blood vessel: | n/a |
47 | chr16:76272351-76272401 | A549 | lung: | n/a |
48 | chr16:76272351-76272401 | NHDF-neo | bronchial: | n/a |
49 | chr16:76272351-76272401 | HepG2 | liver: | n/a |
50 | chr16:76272351-76272401 | ovcar-3 | ovarian: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL18P13 | TF binding region |
RPL18P13 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7186960 | chr16:76271568-76271569 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs561277418 | chr16:76271569-76271570 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs373024941 | chr16:76271575-76271576 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs529156780 | chr16:76271592-76271593 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs150799308 | chr16:76271638-76271639 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs182731643 | chr16:76271657-76271658 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs557163817 | chr16:76271666-76271667 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs7187843 | chr16:76271700-76271701 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs551165538 | chr16:76271703-76271704 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs35281793 | chr16:76271724-76271725 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs16944046 | chr16:76271790-76271791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs536760531 | chr16:76271805-76271806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7187506 | chr16:76271827-76271828 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs16944054 | chr16:76271920-76271921 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs79977797 | chr16:76271930-76271931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553292681 | chr16:76271995-76271996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16944056 | chr16:76271996-76271997 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs144106034 | chr16:76272082-76272083 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs35624555 | chr16:76272084-76272085 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs55943362 | chr16:76272088-76272089 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs187782677 | chr16:76272118-76272119 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs542929491 | chr16:76272142-76272143 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs559715097 | chr16:76272152-76272153 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs149005660 | chr16:76272352-76272353 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs545034188 | chr16:76272366-76272367 | Inactive region | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs558523892 | chr16:76273697-76273698 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs72794930 | chr16:76273713-76273714 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs555418566 | chr16:76274601-76274602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149247841 | chr16:76274620-76274621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562303613 | chr16:76274634-76274635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541755725 | chr16:76274636-76274637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560971250 | chr16:76274649-76274650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144582788 | chr16:76274673-76274674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543487487 | chr16:76274674-76274675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563411632 | chr16:76274681-76274682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531505911 | chr16:76274735-76274736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371081254 | chr16:76274750-76274751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188599527 | chr16:76274757-76274758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548921946 | chr16:76274768-76274769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566070665 | chr16:76274771-76274772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371652396 | chr16:76274787-76274788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547340289 | chr16:76275409-76275410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535535516 | chr16:76275419-76275420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116344056 | chr16:76275439-76275440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12596723 | chr16:76275447-76275448 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
46 | rs146011048 | chr16:76275448-76275449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536336348 | chr16:76275466-76275467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78579137 | chr16:76275481-76275482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549994905 | chr16:76275493-76275494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187048086 | chr16:76275533-76275534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 24585490 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76269400-76272000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr16:76274600-76274800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr16:76275400-76275800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |